mineralNot FDA-approvedOTC supplementSold in the US as an unregulated dietary supplement; no FDA-reviewed indication or standardized dose exists for lithium orotatePrescription lithium (carbonate/citrate) is FDA-approved for bipolar disorder at doses many-fold higher and under blood-level monitoring; the orotate supplement form has not undergone the same reviewA documented case report describes lithium toxicity following use of an internet-purchased lithium dietary supplement, underscoring that unregulated products can vary in potency
Lithium OrotateBenefits, Dosage & Interactions
Lithium orotate is a salt formed from the trace mineral lithium and orotic acid. Unlike pharmaceutical lithium, which is typically prescribed as lithium carbonate or lithium citrate for specific psychiatric conditions, lithium orotate is offered as a dietary supplement. Research on Lithium Orotate focuses on cognition and mood.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Limited — Human observational or case data only — no randomized trials.
Evidence strengthLimited · 2/4
PreclinicalStrong human evidence
Human observational or case data only — no randomized trials.
Whole-body biological half-life
Not applicable
Typical timing
morning
Food rule
with food
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- Survey respondents reported taking OTC lithium orotate products at doses far below prescription lithium carbonate, typically in the low single-digit milligrams of elemental lithium per day, though labeling and actual content varied widely between products[1][2][3]
Reported for Lithium Orotate in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Lithium Orotate entry is written from. Each number matches an inline marker above.
- [1]Lithium orotate: distinct compound or simply Li+ after administration?Hajek T, Munthe S, Licht RW · The British Journal of Psychiatry · 2026 · Peer-reviewed · PMID 42312809
- [2]A Survey Exploring People's Experiences With Lithium Bought as a SupplementStrawbridge R, Myrtle S, Carmellini P, Hampsey E, Cousins DA, Young AH · Canadian Journal of Psychiatry · 2025 · Peer-reviewed · PMID 40152059
- [3]A qualitative exploration of perspectives on taking lithium supplementsBloomfield M, Chebabo-Manning L, Strawbridge R · Therapeutic Advances in Psychopharmacology · 2026 · Peer-reviewed · PMID 42500268
- [4]Lithium toxicity from an Internet dietary supplementPauzé DK, Brooks DE · Journal of Medical Toxicology · 2007 · Peer-reviewed · PMID 18072162
How to track Lithium Orotate doses
Tracking Lithium Orotate well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log Lithium Orotate with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is morning. Take it with food, and record it that way so absorption stays consistent. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run Lithium Orotate through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review Lithium Orotate alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mg
- Time of day and whether it was taken with food
- Taken / skipped / delayed
- Any side effects or notable changes
References & Evidence
Sources on this page that document Lithium Orotate dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Lithium Orotate studied for?
What is Lithium Orotate?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Lithium orotate is a salt formed from the trace mineral lithium and orotic acid. Unlike pharmaceutical lithium, which is typically prescribed as lithium carbonate or lithium citrate for specific psychiatric conditions, lithium orotate is offered as a dietary supplement. It contains a lower concentration of elemental lithium per dose compared to prescription forms.
The historical use of lithium in various forms for mental well-being dates back centuries, with natural lithium-containing waters being recognized for their therapeutic properties. The orotate form emerged in the mid-20th century, proposed to enhance the bioavailability of lithium due to orotic acid's role in facilitating mineral transport across cell membranes, particularly the blood-brain barrier. Proponents suggest this allows for lower doses of elemental lithium to achieve desired effects compared to conventional pharmaceutical lithium.
Globally, lithium orotate is available as a supplement, not regulated as a drug for medicinal purposes in most regions, including the United States. This means its manufacturing, purity, and efficacy claims are not subject to the same stringent oversight as prescription medications. Consumers should be aware of this distinction when considering lithium orotate, and always consult with a healthcare professional before starting any new supplement regimen (NIH ODS, MedlinePlus).
What does the research say about Lithium Orotate?
Tap a section to expand.
The proposed mechanism of action for lithium orotate largely mirrors that of other lithium salts, albeit with the theoretical advantage of enhanced cellular uptake due to the orotate carrier. Orotic acid, a naturally occurring compound, is thought to improve the transport of lithium ions across cell membranes, potentially allowing for lower elemental lithium doses to exert effects within target cells, particularly neurons. However, direct scientific evidence specifically demonstrating superior bioavailability or enhanced brain penetration of lithium orotate compared to other lithium salts in humans is limited and not conclusively established.
Once inside the body, elemental lithium ions are believed to influence several critical cellular pathways related to mood regulation and brain health. Key mechanisms attributed to lithium include:
* **Modulation of neurotransmitter systems:** Lithium impacts the synthesis, release, and reuptake of various neurotransmitters, including serotonin, norepinephrine, and dopamine. This modulation is thought to contribute to its mood-stabilizing effects (DrugBank).
* **Inhibition of inositol monophosphatase (IMPase) and glycogen synthase kinase-3 (GSK-3):** These enzymatic inhibitions are considered central to lithium's therapeutic actions. IMPase inhibition reduces the availability of inositol, a precursor to phosphatidylinositols, which are involved in various cell signaling pathways. GSK-3 inhibition affects numerous cellular processes, including neuronal plasticity, gene expression, and apoptosis. Disruptions in these pathways are implicated in mood disorders (PubChem, DrugBank).
* **Neuroprotection and neurogenesis:** Lithium is thought to promote the growth of new brain cells (neurogenesis) and protect existing neurons from damage. This involves increasing the expression of brain-derived neurotrophic factor (BDNF) and other neurotrophic factors, which support neuronal survival and function (DrugBank).
* **Regulation of intracellular calcium levels:** Lithium can influence calcium signaling within cells, which is crucial for neuronal excitability and synaptic plasticity. By helping to stabilize these processes, lithium may contribute to its mood-regulating properties.
While these mechanisms are well-described for pharmaceutical lithium, the extent to which lithium orotate achieves these effects at typically lower supplemental dosages, and whether its orotate carrier truly confers a significant advantage in terms of cellular delivery, remains an area requiring more targeted research (Examine.com).
Source for this section: Sources for How does Lithium Orotate work?: Jumps to this entry in the sources and references list at the end of the page.
Lithium orotate is primarily explored for its potential role in supporting brain health, particularly in areas related to mood and cognitive function. The asserted benefits are largely extrapolated from the known effects of pharmaceutical lithium, with the understanding that lithium orotate delivers elemental lithium in significantly lower doses.
Potential benefits, often reported anecdotally or in preliminary research, include:
* **Mood Stabilization:** The most commonly cited potential benefit of lithium, even at lower doses, is its capacity to help stabilize mood. This is based on lithium's known effects on neurotransmitter systems (serotonin, dopamine, norepinephrine) and intracellular signaling pathways that are dysregulated in mood imbalances. While high-dose pharmaceutical lithium is a well-established treatment for bipolar disorder (Mayo Clinic), proponents suggest that lower-dose lithium orotate might offer subtle mood support for individuals experiencing less severe mood fluctuations (Examine.com).
* **Neuroprotection and Cognitive Function:** Research on higher-dose lithium indicates neuroprotective effects, including promoting neurogenesis (the growth of new brain cells) and protecting existing neurons from damage. It also influences levels of brain-derived neurotrophic factor (BDNF), which is vital for neuronal health and plasticity. Some believe that these neuroprotective properties might extend to lower-dose lithium, potentially supporting overall cognitive function and resilience against age-related cognitive decline, though robust clinical trials specifically for lithium orotate in these areas are limited (Cochrane Library reviews on lithium for neuroprotection).
* **Support for Brain Health:** Beyond specific mood or cognitive benefits, lithium, at various doses, is being investigated for its broader role in maintaining brain health. This includes its potential involvement in reducing oxidative stress and inflammation within the brain, factors implicated in various neurological conditions. However, the exact impact and efficacy of supplemental lithium orotate for these broader brain health initiatives are still subjects of ongoing research and discussion (NIH ODS).
The scientific evidence for lithium orotate specifically, as opposed to pharmaceutical lithium, is relatively limited, particularly concerning large-scale, placebo-controlled human trials. Much of the understanding of lithium orotate's potential benefits is extrapolated from the extensive research on high-dose lithium carbonate or citrate, with the assumption that the same mechanisms apply at lower elemental lithium concentrations.
* **Mood and Psychiatric Conditions:** The robust evidence for high-dose lithium's efficacy in managing bipolar disorder and reducing suicide risk is well-established in numerous clinical trials and meta-analyses (Cochrane, Mayo Clinic). For lithium orotate, evidence is primarily anecdotal or from small, observational studies. Some proponents cite studies suggesting benefits at lower doses for mood stability, but these are often not rigorous enough to draw definitive conclusions. A review on the broader use of low-dose lithium mentioned its potential, but highlighted the scarcity of specific trials for the orotate form (Examine.com).
* **Neuroprotection and Cognitive Health:** Preclinical studies and some observational human data suggest that higher lithium levels, even within the normal range of water consumption, might correlate with reduced incidence of neurodegenerative diseases and improved cognitive outcomes (PubChem). These findings fuel interest in lithium orotate's potential for neuroprotection. However, direct evidence from clinical trials demonstrating that supplemental lithium orotate concretely prevents cognitive decline or enhances cognitive function in healthy individuals or those with mild cognitive impairment is currently insufficient (NIH ODS, MedlinePlus).
* **Bioavailability:** The claim that orotic acid enhances lithium's bioavailability or brain penetration is theoretically plausible. However, direct comparative studies in humans demonstrating superior absorption or brain uptake of lithium from lithium orotate compared to other lithium salts at equivalent elemental lithium doses are scarce. Some early research in animals suggested improved tissue distribution, but human data remains largely unconfirmed (Examine.com).
In summary, while the beneficial effects of elemental lithium are well-documented at therapeutic doses, the specific efficacy and safety profile of lithium orotate as a dietary supplement, particularly regarding its proposed advantages over other lithium forms, require more comprehensive and rigorous scientific investigation (NIH ODS, MedlinePlus, Examine.com).
While lithium orotate contains a lower amount of elemental lithium than prescription forms, it is still lithium, and therefore carries potential side effects, especially if taken in higher-than-intended doses or if individual sensitivity exists. The risk of side effects generally increases with the elemental lithium dose and individual variability in metabolism and excretion.
Commonly reported or potential side effects, even at supplemental levels, may include:
* **Gastrointestinal Distress:** Nausea, vomiting, diarrhea, and stomach cramps are among the most frequently reported side effects. Taking lithium orotate with food may help mitigate some of these symptoms.
* **Increased Thirst and Polyuria:** Lithium can affect kidney function, leading to increased thirst and more frequent urination. While less pronounced at lower doses, it's a known effect of lithium.
* **Tremor:** A fine hand tremor can occur. This is more commonly associated with higher therapeutic doses but can potentially manifest in sensitive individuals at lower doses.
* **Fatigue or Lethargy:** Some individuals may experience tiredness or a general feeling of sluggishness.
* **Hypothyroidism:** Long-term use of lithium, even at lower doses, can sometimes interfere with thyroid function, leading to hypothyroidism. Regular thyroid monitoring is recommended for those using lithium products (Mayo Clinic).
* **Weight Gain:** Although less common with lower doses, weight gain can be a side effect associated with lithium use.
More serious side effects, such as kidney damage, cardiac arrhythmias, or severe neurological symptoms, are predominantly associated with lithium toxicity, which is less likely but still possible if supplemental doses are misused or combined inappropriately with other substances. It is crucial to monitor for any unusual symptoms.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Despite being available as a supplement, lithium orotate should be approached with caution due to the potential for adverse effects and interactions. The key warnings are related to its active ingredient, elemental lithium.
* **Risk of Lithium Toxicity:** Even at lower doses, the accumulation of lithium in the body can lead to toxicity, especially in individuals with compromised kidney function, dehydration, or when combined with certain medications (e.g., NSAIDs, diuretics, ACE inhibitors). Symptoms of lithium toxicity can include severe nausea, vomiting, persistent diarrhea, muscle weakness, blurred vision, confusion, slurred speech, and seizures. If any signs of toxicity occur, discontinue use immediately and seek emergency medical attention (MedlinePlus).
* **Kidney Function:** Lithium is primarily excreted by the kidneys. Impaired kidney function can lead to lithium accumulation and increased risk of toxicity. Individuals with kidney disease or reduced kidney function should absolutely avoid lithium orotate unless specifically advised and monitored by a nephrologist.
* **Thyroid Function:** Lithium can interfere with thyroid hormone synthesis and release, potentially leading to hypothyroidism. Individuals with pre-existing thyroid conditions, or those who develop symptoms of hypothyroidism (fatigue, weight gain, cold intolerance), should have their thyroid function closely monitored. Regular thyroid function tests are advisable for anyone on long-term lithium orotate (Mayo Clinic).
* **Dehydration and Electrolyte Imbalance:** Conditions leading to dehydration (e.g., fever, vomiting, diarrhea, intense exercise, limited fluid intake) or electrolyte imbalances (e.g., low sodium intake) can increase lithium concentrations in the blood, raising the risk of toxicity. Adequate hydration and stable electrolyte levels are crucial.
* **Pregnancy and Breastfeeding:** Lithium is known to cross the placenta and is excreted in breast milk. It has been associated with potential risks to the fetus and infant. Therefore, lithium orotate is generally contraindicated during pregnancy and breastfeeding unless explicitly recommended and closely monitored by a specialist (FDA drug labels for lithium, EMA SmPC).
* **Underlying Medical Conditions:** Individuals with heart conditions, epilepsy, or other neurological disorders should use lithium orotate with extreme caution and only under strict medical supervision due to potential adverse effects on these systems.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Lithium orotate is contraindicated in several situations due to the risk of severe adverse effects or exacerbation of existing conditions. Always inform your healthcare provider about all supplements and medications you are taking.
* **Severe Renal Impairment:** Because lithium is almost exclusively excreted by the kidneys, individuals with severe kidney disease or significantly impaired renal function are at extremely high risk for lithium accumulation and toxicity. Lithium orotate should not be used in this population (MedlinePlus).
* **Dehydration or Sodium Depletion:** Conditions that lead to significant dehydration (e.g., severe vomiting, diarrhea, febrile illness, strenuous exercise without adequate fluid replacement) or sodium depletion (e.g., low-sodium diet, excessive sweating) can increase lithium levels in the blood to toxic concentrations. Lithium orotate is contraindicated during such episodes.
* **Cardiovascular Disease:** Individuals with certain cardiovascular diseases, especially those with sick sinus syndrome or other severe cardiac arrhythmias, should avoid lithium orotate due to lithium's potential to affect cardiac conduction (DrugBank).
* **Pregnancy and Breastfeeding:** Lithium is classified as a known teratogen (substance that can cause birth defects) and is found in breast milk. Its use is contraindicated during pregnancy and breastfeeding due to potential harm to the fetus or infant. Women of childbearing potential should use effective contraception if considering lithium orotate (FDA drug labels for lithium, EMA SmPC).
* **Untreated Hypothyroidism:** While lithium can induce hypothyroidism, its use is also contraindicated in individuals with existing, untreated hypothyroidism, as it can worsen the condition.
* **Sodium-Restricted Diets:** Individuals on strict sodium-restricted diets may be at higher risk for lithium toxicity, as sodium and lithium compete for reabsorption in the kidneys. This can lead to increased lithium retention.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Combining lithium orotate with certain medications or substances can significantly increase the risk of adverse effects, including lithium toxicity, or reduce its effectiveness. Always inform your healthcare provider about all supplements, over-the-counter medications, and prescription drugs you are taking.
* **Diuretics (Water Pills):** Thiazide and loop diuretics (e.g., hydrochlorothiazide, furosemide) can reduce the renal clearance of lithium, leading to increased blood lithium levels and an elevated risk of toxicity. Close monitoring and dose adjustment by a clinician are essential if co-administration is unavoidable.
* **Nonsteroidal Anti-Inflammatory Drugs (NSAIDs):** NSAIDs, such as ibuprofen, naproxen, and celecoxib, can reduce lithium excretion by the kidneys, leading to higher lithium concentrations and an increased risk of toxicity. Aspirin, however, appears to have less of an effect. Avoid chronic concurrent use of NSAIDs with lithium products (MedlinePlus).
* **ACE Inhibitors and Angiotensin II Receptor Blockers (ARBs):** Medications for high blood pressure like lisinopril, enalapril, and losartan can decrease lithium excretion, potentially leading to toxic lithium levels. Close monitoring is crucial.
* **Other Serotonergic Drugs:** While less documented for lithium orotate specifically, combining any lithium product with other drugs that increase serotonin activity (e.g., SSRIs, SNRIs, MAOIs, triptans for migraines, St. John's Wort) carries a theoretical risk of serotonin syndrome, especially at higher lithium doses. Monitor for symptoms like agitation, confusion, rapid heart rate, and fever.
* **Calcium Channel Blockers:** Some calcium channel blockers (e.g., verapamil, diltiazem) may interact with lithium, potentially increasing neurotoxicity even at therapeutic lithium levels.
* **Metronidazole (Antibiotic):** This antibiotic can significantly increase plasma lithium concentrations, leading to toxicity. Concurrent use should generally be avoided.
* **Potassium-Sparing Diuretics:** While less commonly associated with lithium interaction than thiazide or loop diuretics, these can also alter electrolyte balance and should be used with caution.
* **Caffeine:** High intake of caffeine can increase lithium clearance, potentially reducing its effectiveness. On discontinuation of caffeine, lithium levels might rise.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Lithium orotate is typically taken once daily. Taking it in the morning is often suggested to align with daily routines and to potentially reduce the likelihood of nocturnal polyuria (increased urination at night) for some individuals. It is generally recommended to take lithium orotate with food. This can help minimize gastrointestinal side effects such as nausea or stomach upset, which are common with many mineral supplements (Examine.com).
Consistency in timing, such as taking it at roughly the same time each day, may help maintain more stable levels in the body, although the half-life of lithium is relatively long (around 24 hours), meaning minor variations in timing are unlikely to have a significant impact.
As individual responses can vary, some individuals might find other timing strategies more suitable for their personal routines or to manage potential side effects. Always adhere to the guidance of a qualified clinician regarding optimal timing and any specific instructions for your situation.
Source for this section: Sources for When should you take Lithium Orotate?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Lithium Orotate?
No interaction rules currently on file for this compound in DoseRoutine.
Frequently asked questions about Lithium Orotate
Lithium Orotate is a mineral. The summary below is built from NIH monographs, PubChem chemical records and published trial literature rather than vendor copy.
Lithium Orotate is commonly discussed in the context of supporting brain. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For Lithium Orotate, it is typically taken in the morning and it is usually taken with food. Always follow the specific dose your clinician or the product label prescribes.
Lithium Orotate carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Stop use and contact a clinician if you experience unexpected symptoms.
Interaction risk for Lithium Orotate comes from the rest of the stack: other minerals, prescription medicines, hormone therapy and peptides. Because Lithium Orotate is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Lithium Orotate with no sign-up.
There is no single answer for Lithium Orotate plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing Lithium Orotate with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Lithium Orotate varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the morning. Most protocols have it taken with food. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Lithium Orotate depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Lithium Orotate the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Lithium Orotate?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Lithium orotate: A superior option for lithium therapy?(opens PubMed in a new tab)Brain Behav · 2021 · PMID 34196467 · https://pubmed.ncbi.nlm.nih.gov/34196467/
- 2.Lithium and coronaviral infections. A scoping review(opens PubMed in a new tab)F1000Res · 2020 · PMID 32518634 · https://pubmed.ncbi.nlm.nih.gov/32518634/
- 3.The clinical applications of lithium orotate. A two years study(opens PubMed in a new tab)Agressologie · 1973 · PMID 4607169 · https://pubmed.ncbi.nlm.nih.gov/4607169/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 23686432(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/23686432
Verify at
Publisher search links for Lithium Orotate. These are places to check the information — they are not citations, so they are not numbered.
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- European Medicines Agency(publisher search, opens in a new tab)European Medicines Agency · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Lithium Orotate?
Plain-text summary, safe to quote verbatim:
Lithium orotate is a salt formed from the trace mineral lithium and orotic acid. Unlike pharmaceutical lithium, which is typically prescribed as lithium carbonate or lithium citrate for specific psychiatric conditions, lithium orotate is offered as a dietary supplement. Research on Lithium Orotate focuses on cognition and mood.
Source: DoseRoutine — https://doseroutine.com/library/lithium-orotate
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Lithium Orotate — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/lithium-orotate
What compounds are similar to Lithium Orotate?
Others in the mineral category or studied for the same goals.
Which goals is Lithium Orotate used for?
Other compounds studied for the same benefits as Lithium Orotate.
Continue exploring
See every compound DoseRoutine catalogs for these goals.